Literature DB >> 17055782

Distinct destructive signal pathways of neuronal death in Alzheimer's disease.

Yong Shen1, Ping He, Zhenyu Zhong, Carrie McAllister, Kristina Lindholm.   

Abstract

Abundant neuron loss is a major feature of Alzheimer's disease (AD). Hypotheses for this loss include abnormal amyloid precursor protein processing (i.e. excess Abeta production, protein aggregation or misfolding), oxidative stress, excitotoxicity and inflammation. Neuron loss is a major cause of dementia in AD; however, it seems that there is no definitive pathway that causes cell death in the AD brain. Here, we examine the hypotheses for neuron loss in AD and pose the argument that the means by which neurons degenerate is irrelevant for cognitive decline. The best treatment for cognitive decline is to prevent the toxicity that first sets the neuron on its path to destruction, which is the production of Abeta peptide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055782     DOI: 10.1016/j.molmed.2006.10.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  15 in total

1.  Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.

Authors:  H Hampel; S Lista
Journal:  J Nutr Health Aging       Date:  2013-01       Impact factor: 4.075

2.  Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons.

Authors:  Ping He; Qiang Liu; Jie Wu; Yong Shen
Journal:  FASEB J       Date:  2011-10-07       Impact factor: 5.191

3.  High activities of BACE1 in brains with mild cognitive impairment.

Authors:  Xin Cheng; Ping He; Taehee Lee; Hailan Yao; Rena Li; Yong Shen
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

4.  Apoptosis and in vitro Alzheimer disease neuronal models.

Authors:  P Calissano; C Matrone; G Amadoro
Journal:  Commun Integr Biol       Date:  2009

Review 5.  Capturing adenylyl cyclases as potential drug targets.

Authors:  Sandra Pierre; Thomas Eschenhagen; Gerd Geisslinger; Klaus Scholich
Journal:  Nat Rev Drug Discov       Date:  2009-04       Impact factor: 84.694

6.  PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients.

Authors:  Milena Damjanac; Guylène Page; Stéphanie Ragot; Guillaume Laborie; Roger Gil; Jacques Hugon; Marc Paccalin
Journal:  J Cell Mol Med       Date:  2009-02-04       Impact factor: 5.295

7.  Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease.

Authors:  Hong Jiang; Harald Hampel; David Prvulovic; Anders Wallin; Kaj Blennow; Rena Li; Yong Shen
Journal:  Mol Neurodegener       Date:  2011-10-06       Impact factor: 14.195

8.  Long-term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of β-secretase in a mouse model of Alzheimer's disease.

Authors:  Ping He; Xin Cheng; Matthias Staufenbiel; Rena Li; Yong Shen
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

Review 9.  Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?

Authors:  Wenjie Luo; Anna Rodina; Gabriela Chiosis
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

10.  Protective effect of chronic administration of pelargonidin on neuronal apoptosis and memory process in amyloid-beta-treated rats.

Authors:  Nazita Alisavari; Sara Soleimani-Asl; Mohammad Zarei; Nasrin Hashemi-Firouzi; Siamak Shahidi
Journal:  Avicenna J Phytomed       Date:  2021 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.